198 related articles for article (PubMed ID: 23645748)
1. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
Uzgare RP; Sheets TP; Johnston DS
Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
[TBL] [Abstract][Full Text] [Related]
2. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers.
Vogl TJ; Zangos S; Scholtz JE; Schmitt F; Paetzold S; Trojan J; Orsi F; Lotz G; Ferrucci P
Rofo; 2014 Oct; 186(10):937-44. PubMed ID: 24729409
[TBL] [Abstract][Full Text] [Related]
3. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
Deneve JL; Choi J; Gonzalez RJ; Conley AP; Stewart S; Han D; Werner P; Chaudhry TA; Zager JS
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1480-7. PubMed ID: 22699779
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
Dewald CLA; Becker LS; Maschke SK; Meine TC; Alten TA; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
[TBL] [Abstract][Full Text] [Related]
6. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
Artzner C; Mossakowski O; Hefferman G; Grosse U; Hoffmann R; Forschner A; Eigentler T; Syha R; Grözinger G
Cancer Imaging; 2019 May; 19(1):31. PubMed ID: 31146793
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
[TBL] [Abstract][Full Text] [Related]
8. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review.
Vogel A; Gupta S; Zeile M; von Haken R; Brüning R; Lotz G; Vahrmeijer A; Vogl T; Wacker F
Adv Ther; 2017 Jan; 33(12):2122-2138. PubMed ID: 27798773
[TBL] [Abstract][Full Text] [Related]
9. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter.
Dewald CLA; Meine TC; Winther HMB; Kloeckner R; Maschke SK; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Renne J; Hinrichs JB
Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1441-1448. PubMed ID: 31089781
[TBL] [Abstract][Full Text] [Related]
10. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
11. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
Veelken R; Maiwald B; Strocka S; Petersen TO; Moche M; Ebel S; Denecke T; Rehak M; Struck MF; Forstmeyer D; Rademacher S; Seehofer D; Berg T; van Bömmel F
Cardiovasc Intervent Radiol; 2022 Feb; 45(2):218-222. PubMed ID: 34716470
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.
Kirstein MM; Marquardt S; Jedicke N; Marhenke S; Koppert W; Manns MP; Wacker F; Vogel A
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2113-2121. PubMed ID: 28634727
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.
Chang YF; Li LL; Wu CW; Liu TY; Lui WY; P'eng FK; Chi CW
Cancer; 1996 Jan; 77(1):14-8. PubMed ID: 8630921
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.
Miklášová N; Fischer-Fodor E; Lönnecke P; Tomuleasa CI; Virag P; Schrepler MP; Mikláš R; Dumitrescu LS; Hey-Hawkins E
Eur J Med Chem; 2012 Mar; 49():41-7. PubMed ID: 22305340
[TBL] [Abstract][Full Text] [Related]
15. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma.
Dewald CLA; Hinrichs JB; Becker LS; Maschke S; Meine TC; Saborowski A; Schönfeld LJ; Vogel A; Kirstein MM; Wacker FK
Rofo; 2021 Aug; 193(8):928-936. PubMed ID: 33535258
[TBL] [Abstract][Full Text] [Related]
16. Chemosaturation of the Liver - an Update.
Ebel S; Struck MF; van Boemmel F; Beeskow AB; Gößmann H; Denecke T
Rofo; 2023 Jan; 195(1):30-37. PubMed ID: 35977553
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
Gong SJ; Jin CJ; Rha SY; Chung HC
Cancer Lett; 2004 Oct; 214(2):215-24. PubMed ID: 15363548
[TBL] [Abstract][Full Text] [Related]
18. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
Vogel A; Ochsenreither S; Zager JS; Wacker F; Saborowski A
Cancer Treat Rev; 2023 Feb; 113():102501. PubMed ID: 36587472
[TBL] [Abstract][Full Text] [Related]
19. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
Gu J; Yamamoto H; Lu X; Ngan CY; Tsujino T; Konishi K; Takemasa I; Ikeda M; Nagata H; Hashimoto S; Matsuzaki T; Sekimoto M; Takagi A; Monden M
Digestion; 2006; 74(1):19-27. PubMed ID: 16988507
[TBL] [Abstract][Full Text] [Related]
20. In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.
van Iersel LB; Koudijs TM; Hoekman EJ; Janssen-van Rhijn CM; Vahrmeijer AL; Nortier JW; van de Velde CJ; Gelderblom H; Kuppen PJ
J Surg Res; 2011 May; 167(2):273-8. PubMed ID: 20036390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]